share_log

Veru Inc | 8-K: Veru Inc Announced Clinical Data from Its Discontinued Phase 3 ARTEST Clinical Trial of Enobosarm Monotherapy

SEC announcement ·  Sep 11, 2023 07:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more